Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa

Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa

<p>Abstract</p> <p>Background</p> <p>The importation of malaria to non-endemic countries remains a major cause of travel-related morbidity and a leading cause of travel-related hospitalizations. Currently they are three priority medications for malaria prophylaxis to We...

Full description

Bibliographic Details
Main Authors:	Hatz Christoph, Van Herck Koen, Blank Patricia R, Widmer Lukas L, Schlagenhauf Patricia
Format:	Article
Language:	English
Published:	BMC 2010-09-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/10/279

Similar Items

The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
by: Mühlberger Nikolai, et al.
Published: (2007-08-01)

The position of mefloquine as a 21<sup>st </sup>century malaria chemoprophylaxis
by: Regep Loredana, et al.
Published: (2010-12-01)

Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries
by: Coutinho Francisco AB, et al.
Published: (2011-05-01)

Malaria Chemoprophylaxis for Travelers: The Knowledge of Physicians in the State of Qatar, 2017
by: Ahmad Bawazir, et al.
Published: (2018-05-01)

Survey and Analysis of Chemoprophylaxis Policies for Domestic Travel in Malaria-Endemic Countries
by: Baird, J.K, et al.
Published: (2022)

Chemoprophylaxis and Malaria Death Rates
by: Gérard Krause, et al.
Published: (2006-03-01)

Travellers' malaria - 'one shoe does not fit all'
by: Hommel Marcel, et al.
Published: (2011-05-01)

Determining utility values related to malaria and malaria chemoprophylaxis
by: Coyle Doug, et al.
Published: (2010-04-01)

Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria
by: Naing C, et al.
Published: (2012-08-01)

The role of rifaximin in the treatment and chemoprophylaxis of travelers&#39; diarrhea
by: Hoonmo L Koo, et al.
Published: (2009-10-01)

A systematic review of factors affecting adherence to malaria chemoprophylaxis amongst travellers from non-endemic countries
by: Julian Ahluwalia, et al.
Published: (2020-01-01)

Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa
by: Pradines Bruno, et al.
Published: (2010-02-01)

U.S. Army Enlisted Soldiers' Adherence to Prescribed Malaria Chemoprophylaxis in Afghanistan
by: Brisson, Michael Paul
Published: (2015)

Community based malaria control through chemotherapy and chemoprophylaxis in Saradidi, Kenya
by: Kaseje, Dan Celement Owino
Published: (1989)

Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization
by: Wiebke Nahrendorf, et al.
Published: (2015-02-01)

Compliance with Primary Malaria Chemoprophylaxis: Is Weekly Prophylaxis Better Than Daily Prophylaxis?
by: Rodrigo C, et al.
Published: (2020-11-01)

Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis ?
by: Rachel Kotila, et al.
Published: (2007-03-01)

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines
by: Saliou Pierre, et al.
Published: (2005-11-01)

Yellow Fever importation to China – a failure of pre- and post-travel control systems?
by: Patricia Schlagenhauf
Published: (2017-07-01)

Imported Infectious Disease and Purpose of Travel, Switzerland
by: Lukas Fenner, et al.
Published: (2007-02-01)

Malaria chemoprophylaxis recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study
by: Bisoffi Zeno, et al.
Published: (2011-05-01)

Chemoprophylaxis of Tropical Infectious Diseases
by: William J. H. McBride
Published: (2010-05-01)

Chemoprophylaxis and HAART Therapy in Botswana
by: Essex M
Published: (2005-12-01)

Review of chemoprophylaxis in leprosy contacts
by: Sergio Souza Cunha
Published: (2014-09-01)

Unexpectedly long incubation period of <it>Plasmodium vivax </it>malaria, in the absence of chemoprophylaxis, in patients diagnosed outside the transmission area in Brazil
by: da Silveira Bressan Clarisse, et al.
Published: (2011-05-01)

Rethinking Chemoprophylaxis for Total Ankle Replacement
by: Adam J. Farrier MBChB, et al.
Published: (2016-08-01)

Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area
by: Boutin Jean-Paul, et al.
Published: (2009-10-01)

Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997–2016)
by: Jae Hyoung Im, et al.
Published: (2018-08-01)

Pre-exposure chemoprophylaxis for HIV: It is time
by: Smith Stephen M
Published: (2004-07-01)

Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.
by: Sanne-Meike Belderok, et al.
Published: (2013-01-01)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.
by: Beatrix Huei-Yi Teo, et al.
Published: (2015-01-01)

Cost-Effectiveness Analysis of Influenza A (H1N1) Chemoprophylaxis in Brazil
by: Luisa von Zuben Vecoso, et al.
Published: (2019-09-01)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
by: Manuel L. Fernandez Guerrero, et al.
Published: (2007-09-01)

Correction: Adherence to Chemoprophylaxis and Anti-Circumsporozoite Seroconversion in a Prospective Cohort Study of Dutch Short-Term Travelers.
Published: (2014-01-01)

Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis
by: Nevin Remington L
Published: (2009-08-01)

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
by: Liesbeth F Mieras, et al.
Published: (2018-10-01)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

Tuberculosis in children – from diagnostics to chemoprophylaxis and treatment
by: Joanna Kosińska, et al.
Published: (2014-06-01)

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy
by: Duthie MS, et al.
Published: (2016-04-01)

Effectiveness study on aspirin chemoprophylaxis in patients with diabetes
by: Cheng-Ching Lin, et al.
Published: (2015)